These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4552465)

  • 1. Cell-mediated immunity in Herpesvirus hominis infections.
    Wilton JM; Ivanyi L; Lehner T
    Br Med J; 1972 Mar; 1(5802):723-6. PubMed ID: 4552465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immunity and antibodies to Herpesvirus hominis type 1 in oral leukoplakia and carcinoma.
    Lehner T; Wilton JM; Shillitoe EJ; Ivanyi L
    Br J Cancer; 1973 May; 27(5):351-61. PubMed ID: 4351511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.
    Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL
    Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immune responses in oral disease: a review.
    Lehner T
    J Oral Pathol; 1972; 1(1):39-58. PubMed ID: 4626994
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.
    Russell AS; Percy JS; Kovithavongs T
    Infect Immun; 1975 Feb; 11(2):355-9. PubMed ID: 163220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.
    David JR; David RR
    Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential changes in T and B lymphocyte responses to Herpes simplex virus in man.
    Shillitoe EJ; Wilton JM; Lehner T
    Scand J Immunol; 1978; 7(5):357-66. PubMed ID: 307272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune response in genital herpes simplex virus infection.
    Corey L; Reeves WC; Holmes KK
    N Engl J Med; 1978 Nov; 299(18):986-91. PubMed ID: 211414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans.
    Shillitoe EJ; Wilton JM; Lehner T
    Infect Immun; 1977 Oct; 18(1):130-7. PubMed ID: 198372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity to herpes simplex virus in man.
    Russell AS
    Am J Clin Pathol; 1973 Dec; 60(6):826-30. PubMed ID: 4357123
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequential changes in cell-mediated immune responses to herpes simplex virus following primary herpetic infection in man.
    Shillitoe EJ; Wilton JM; Lehner T
    IARC Sci Publ (1971); 1978; (24 Pt 2):753-8. PubMed ID: 221399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitis.
    Møller-Larsen A; Haahr S; Black FT
    Infect Immun; 1978 Nov; 22(2):445-51. PubMed ID: 730366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental immunosuppression induced by herpes simplex virus.
    Cappel R; Henry C; Thiry L
    Arch Virol; 1975; 49(1):67-72. PubMed ID: 172950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated and humoral immune responses or renal transplant recipients with cytomegalovirus infections.
    Lopez C; Simmons RL; Park BH; Najarian JS; Good RA
    Clin Exp Immunol; 1974 Apr; 16(4):565-73. PubMed ID: 4377553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiencies in chronic muco-cutaneous candidosis.
    Lehner T; Wilton JM; Ivanyi L
    Immunology; 1972 May; 22(5):775-87. PubMed ID: 4336639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell mediated immunity to herpesvirus type 1 in carcinoma and pre-cancerous lesions.
    Lehner T; Shillitoe EJ; Wilton JM; Ivanyi L
    Br J Cancer Suppl; 1973 Aug; 1():128-34. PubMed ID: 4374226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte-monocyte defect associated with anergy and recurrent infections.
    Louie JS; Goldberg LS
    Clin Exp Immunol; 1972 Jul; 11(3):469-74. PubMed ID: 4625400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy of recurrent Herpes simplex diseases].
    Wassilew SW
    Hautarzt; 1979 Jun; 30(6):287-91. PubMed ID: 378899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic mucocutaneous candidiasis accompanied by enhanced antibody production.
    Takeya K; Nomoto K; Matsumoto T; Miyake T; Himeno K
    Clin Exp Immunol; 1976 Sep; 25(3):497-500. PubMed ID: 786522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic immunity in herpetic keratitis.
    Easty DL; Carter C; Funk A
    Br J Ophthalmol; 1981 Feb; 65(2):82-8. PubMed ID: 7006678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.